TARDBP and amyotrophic lateral sclerosis: An involvement of NF-κB in ALS is further supported by the evidence that pharmacological inhibition of this pathway conferred beneficial effects in mouse models of ALS, including attenuation of TDP-43 pathology in motor neurons (Swarup et al., 2011b; Dutta et al., 2017).